OGN vs USO · P/E 3.4, rev $3.02B vs rev -$362.0M
Organon & Co (OGN) versus United States Oil Fund LP (USO) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
United States Oil Fund LP (USO) common stock listed on US.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported USO revenue for 2026-06-30 was -$362.0M. Net income was -$365.4M. Revenue was down 136.7% from 2026-03-31 to 2026-06-30. USO currently screens at market cap $0.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. USO currently screens at market cap $0.
Not investment advice. Open the OGN and USO stock pages for the full models.
Not investment advice.